STOCKS TELEGRAPH

Author: ST Staff

On What Basis Did BTCS Stock Rise 34%?
Last session, BTCS Inc (OTCQB: BTCS) gained 34.58%, sending its market cap to $42.24M, closing at $0.7550. The BTCS stock has traded between $0.5620 and $0.7599 on Friday. There are 55.96M shares outstanding versus 44.41M float for the pink sheets company. BTCS stock soared after providing quarterly results.

How BTCS performed?

BTCS was one of the early players in the U.S. focused on blockchain and the digital currency ecosystem. As a blockchain infrastructure operator, BTCS proactively processes and validates blockchain transactions on Ethereum’s proof-of-stake blockchain and receives reward digital assets. Through this platform, BTCS is establishing a stake and delegation system to facilitate the use of cryptocurrencies and a non-custodial system.

BTCS’ first-quarter results were announced last week along with other developments.

Q1 Highlights/Updates:
- By March 31, 2021, the stockholders’ equity stood at $15.4 million, an increase of $14.3% over the December 31, 2020 period
- Non-cash charges led BTCS to a net loss of $6.8 million.
- A non-GAAP financial measure of adjusted EBITDA of $2.4 million was reported.
- As of March 31, 2021, digital assets of BTCS were valued at about $20.1 million, up 411% from December 31, 2020, and 7,516% from March 31, 2020.
- With operations only fully kicking off in the last month of Q1 2021, the Ethereum 2.0 blockchain staking operation went from a single node to 240 nodes.
- This generated $72K for BTCS with 100% of revenue coming from ETH.
- A registered direct offering and equity line raised $11.5 million for an average price of $1.03 per share.
- BTCS was personally invested by the company’s management and board director for $1.1 million.
- The cash position at BTCS as of March 31, 2021, was $3.4 million.
May 17, 2021
How Did The CYIO Stock Skyrocket, Jumping 35%?
Shares of CYIOS Corporation (OTCPink: CYIO), a company focused on developing and marketing specialty branded products in the Health and Wellness markets, were up 35.00% at its last close, rising to $0.2480.

Over the last week, CYIOS stock lost -9.82% compared to a monthly loss of -17.33%. While CYIO stock was more upbeat without current news, recent developments might provide more insight into CYIO.

Did anything happen recently?

Helio Lending and Choice Wellness Inc. are subsidiaries of CYIOS Corp. Helio’s CeFi Aggregator platform serves as CYIO’s platform for cryptocurrency lending. Choice Wellness offers products under the “DR’s CHOICE” and “24” brand names, which are all geared towards the Health and Wellness market. In addition to developing, distributing, and licensing proprietary software, CYIO strives to evaluate potential acquisitions.

CYIOS has recently completed the acquisition of Helio Lending, Pty Ltd. (Helio), a privately jeld business.
- It was an all-share restricted stock transaction with 50% of the restricted common shares held in escrow and issuable upon performance milestones.
- Helio’s proprietary platform offers cryptocurrency holders interest on deposits and the ability to secure loans collateralized by certain cryptocurrencies.
- In addition, the company announced the appointment of Marko Radisic to its Director of Communications and Public Relations, who will be responsible for media relations, investor relations, and sponsorships.
How it will benefit CYIO?

Helio’s acquisition represents an important milestone for CYIOS Corp (CYIO) and will position the company to expand into an emerging market for cryptocurrency, which CYIO believes should continue to show significant market cap growth for the long haul. The new director has also been appointed in line with CYIO’s strategy to promote an advisory board composed of the best minds in crypto-assets and real estate financing.
May 17, 2021
What Motivated Tamino (TINO) Stock To Climb 41%?

The previous close for Tamino Minerals Inc [OTCPink: TINO] was 41.98% higher at $0.0115. Compared to its 1-month average volume of 2.20M, Tamino stock saw volume of 12.60M. The last 52-week price range for TINO stock was $0.0010 to $0.0220. TINO stock spiked following news of plans to commence litigation over banning convertible noteholders from trading in penny stocks.

Who banned the trading?

Tamino is an exploration company searching for precious metals, copper, lead, and zinc. Mineral exploration is currently done by TINO in Mexico. El Volcan Project is a highly prospective gold and silver area in Mexico, home to TINO’s El Volcan Property.

Tamino has been notified by the Securities and Exchange Commission “SEC” that this Convertible Noteholder is prohibited from trading penny stocks.

They will therefore be unable to convert the Note they currently possess into stock. Because TINO was posting on social media, it is unlikely to have any conversions. The Penny Stock Market is effectively regulated by government authorities, according to TINO.

As TINO moves towards becoming Pink Current Information in order to access a much higher Financial Reporting Tier, it published that Material Information to its shareholders. TINO plans to reveal more details about its ongoing geological exploration activities shortly.

How it will impact?

Tamino (TINO) negotiated with Noteholder a two-staged financing in 2014 and, because of the trading ban, is unable to proceed with any further transactions. In the litigation, TINO plans to provide further information as it proceeds, including whether it seeks punitive damages.

May 17, 2021
Is There Any Reason As To Why The BRAVADA Stock Skyrocketed 44%?
As of the previous close, BRAVADA International Ltd (OTCPK: BRAV) jumped up 44.23 percent to $0.0075. In contrast to its monthly average volume of 2.92M, BRAVADA stock traded 12.64M shares in volume on the day. After BRAV stock rose in absence of current news, we can then refer to the recent developments in order to get a better understanding of the stock.

How did things go recently?

BRAVADA International operates in the media and internet sector. Through its proprietary methodology of creating, developing, and operating retail and wholesale websites, BRAV owns and curates online properties. In addition to consumer-level products and services, BRAV offers B2B services.

A reverse split of BRAVADA is not expected to be considered until 2022, unless a material event affects the board’s decision, announced the company on Friday.
- A reverse split of 50 for 1 was announced by BRAV on March 12.
- There was, however, a problem dating back to 2001 when the BRAV was operating under previous management as Teltran.
- Teltran’s management did not file required paperwork for years 2001 through 2007, which did not represent a concern at the time.
- As early as late 2008, Danny Alex, founder, and CEO of BRAVADA International Ltd., acquired Teltran and changed its name to BRAVADA International Ltd.
The focus of BRAV is on what?

CEO Danny Alex, who is working at an uncompromised pace to complete the projects scheduled for this fiscal year, has an aggressive business plan for expanding BRAVADA (BRAV)’s operations in 2021. BRAV decided to focus on its business plan in 2022 and revisit corporate actions at that point and spend the time necessary to rectify the problem at that time.
May 17, 2021
On What Basis Did Digihost (HSSHF) Stock Rise 42%?
In the last session, Digihost Technology Inc (OTCQB: HSSHF) stock gained 42.88% to $2.0289. A total of 2.53M shares traded hands during the session, with Digihost stock ranging from $1.55 to $2.050 in price. The news of a deal to acquire bitcoin miners and increase hash rate lifted the HSSHF stock on Friday.

Bitcoin miner deal in brief:

Being a blockchain technology company focused primarily on Bitcoin mining, Digihost aims to develop growth-oriented blockchain solutions. Mining facilities owned by HSSHF are located in the Finger Lakes region, with 78.7MW of low-cost power available.

There are options to increase that amount to 102MW. A rate of 200PH is currently being hashed at HSSHF, with potential to reach 3EH after the previously announced acquisition of a 60MW power plant is completed.

On Friday, a Digihost press release revealed that it had acquired 9,900 Bitcoin miners, increasing the HSSHF’s current hash rate by approximately 925PH to 1.145EH.
- HSSHF previously announced the purchase in a news release on May 12, 2021.
- HSSHF is funding the purchase of the Miners by borrowing approximately CA$54,000,000 from equity financings closed since the beginning of 2021.
- The HSSHF also made a simultaneous agreement with Northern Data AG, through which the Northern Data will provide services to the HSSHF, including the installation and hosting of the Miners.
- Deliveries and installations of the Miners are expected to occur incrementally from August to December this year, with full operation expected by the end of 2022.
Cost to HSSHF:

A development of systems to supply the mobile data centers with energy from the facility is expected to cost Digihost (HSSHF) approximately US$4.5 million, which HSSHF expects to fund from its previous equity financings.
May 17, 2021
How Does The Viaderma (VDRM) Stock Price Increase By 48%?
In trading on Friday, the stock of ViaDerma, Inc (OTCPink: VDRM) gained 48.06 percent to $0.0305 and has been trading between $0.0200 and $0.0320. With a volume average of over 16.71M shares, ViaDerma stock rose over 106.08% in the last month.

When looking at its performance over the past three months, VDRM stock gained over 38.64% while its average volume amounted to 29.72M. On Friday, VDRM’s stock rose after it was announced a large hospital network was set to place the first order.

What was the order for?

As a publicly-traded specialty pharmaceutical company, ViaDerma is dedicated to improving the lives of patients. VDRM’s commitment to bringing new products to market and licensing its innovative technology to drug manufacturers across a wide array of therapeutic areas is formidable.

An initial order for Vitastem, a wound care product from ViaDerma, has been near finalization with a major healthcare network, announced the company on Friday.
- Late last year, VDRM completed successful testing of the product, allowing it for sale.
- Moreover, ViaDerma confirmed that its first-quarter financial reports are being completed at that moment and are scheduled to be filed before 4:00 PM today.
- Also, the previous Attorney Letter pertaining to Current Information recently expired, causing the Company to receive a temporary Yield sign indicating a Pink Limited Information filing status.
VDRM going forward:

As soon as the initial purchase is completed, hundreds of hospitals, nursing homes, and hospices will have VDRM’s Vitastem integrated into their networks. Also, it is expected that ViaDerma (VDRM)’s attorney will complete and file a new letter, which should return the company to Current Status in a few days.
May 17, 2021
Did Anything Cause PIFR Stock To Rise 52%?
Premier Information Management Inc (OTCPink: PIFR) closed at $0.0700 on Friday, up 52.17 percent. PIFR stock has traded in a day range of $0.0618 to $0.1100. The Premier Information stock recorded a gain of 12566.67% in the past 12 months with a 52-week high of $0.1100 and over $4.12M in market capitalization. As a result of the reverse merger news, the PIFR stock surged.

Reverse merger in brief:

It was announced on Friday that Premier Information had entered into a reverse merger agreement with Cannabinoid Biosciences, Inc. Latest information on this strategic move, along with other pertinent things provided by PIFR is as follows:
1. A newly formed management team and an entirely new management infrastructure were the result of this reverse merger.
2. As part of this transaction, no reverse split will take place, so current shareholders will not lose their positions, thus protecting the value of their existing investments.
3. At the moment, the CBDX team consists of four key individuals with plans to ramp up as targeted acquisitions are rolled out.
4. The share structure at OTC Markets is current as of past Friday.
5. In addition to maintaining the company’s pink status on OTC Markets, this move will also require updating the company’s public disclosures.
6. Following the appropriate time frame, the company will change its name and ticker symbol.
Why PIFR issued a press release?

Because Premier Information (PIFR) and Cannabinoid Biosciences both believe that the reverse merger agreement will work, the companies decided that a simple press release would be helpful. PIFR’s press release also clarifies recent inquiries about its long-term future.
May 17, 2021
Athenex Inc. (NASDAQ:ATNX) stock surged in the current trading session; here’s why

In the current trading session, Athenex Inc. (ATNX) shares surged by 38.27% to the price of $5.13 at the last check. ATNX stock previously closed at $3.71. The ATNX stock volume traded 187.08 million shares, while the average three-month trading volume has been 3.31M. In the past year, up-to-date ATNX shares have slumped by -59.05% and the ATNX stock has furthermore slumped -10.17% in the past week. In the past three and six months, the ATNX stock shed -73.42% and-67.46%. Furthermore, Athenex Inc. has a current value in the market worth $351.00 million and has 93.39 million outstanding shares.

What is recently happening in Athenex Inc.?

Athenex Inc (NASDAQ: ATNX) announced on 4^th May 2021, that it has acquired the leading developer of off-the-shelf CAR-NKT cell immunotherapies. This company is known as Kuur Therapeutics, Inc. which develops treatments for solid and hematological malignancies.

Athenex is looking forward to working and collaborating with Kuur Therapeutics and bringing its innovative platform to Athenex’s own. The potential of this platform merging with the TCR program of Athenex can significantly climb the combined company to a leading position in the cell therapy market. Athenex had eyed this deal for other possible collaboration and combined resource synergy for future pipeline deals.

The Athenex has the first generation of cell therapy treatments that are focused on autologous CAR-T. However, these cell therapy treatments have limitations. These limitations are exactly why Kuur Therapeutics’ NKT cell platform can become significantly relevant. The NKT cell platform when combined with the TCR program, can bring out innovative new approaches for the NKT cell platform which can provide a solution to address the known limitations associated with the cell therapy treatments.

News of the Athenex-Kuur merger has surged the ATNX stock

CAR-NKT cells are unique compared to other cell therapy-based immune effector cells due to their certain advantages over them. The acceleration of providing effective treatment for solid and hematological tumors will give Athenex operations and stock an edge in the cell therapy market. Investors are rounding up towards this newly found potential and hoping for operation and profit growth in the company as well as improvement in the performance of ATNX stock. The news of the acquisition caused the ATNX stock to rise in the premarket trading session today.

Definitive agreements in the merger deal

The agreement undersigns Athenex to an upfront payment of $70 million to Kuur Therapeutics’s shareholders which also includes certain former employees and directors. This consists primarily of equity in ATNX common stock. Athenex has also made it eligible for the shareholders to receive up to $115 million of milestone payments. The company will offer these payments in either cash or common stock provision which is at its sole discretion.

May 5, 2021
Why Sonnet BioTherapeutics Holdings, Inc. (SONN) stock is rising today?

Sonnet BioTherapeutics Holdings, Inc. (SONN) today announced the completion of Licensing agreement with New Life Therapeutics(NLT) after which the SONN stock price saw an uptrend of 6.75% to reach $2.53 a share as of this writing. SONN stock soared in the previous trading session and went up by 17.91% at closing. Let’s deep dive to explore more of it.

Completion of Licensing Agreement:

Sonnet BioTherapeutics Holdings, Inc. is a biotechnology company focused on the area of oncology for the development of the platform for biologic medicines for single as well as multipurpose actions. The execution of a definitive agreement of SONN stock with NLT is for of license of low-dose Interleukin 6 for the treatment of Diabetic Peripheral Neuropathy. The ASEAN countries included under the licensed territories are Singapore, Indonesia, Malaysia, Thailand, The Philippines, Cambodia, Vietnam, Myanmar, Brunei, and Lao PDR.

According to the definitive agreement, SONN stock is eligible to receive payment of $1.0 Million from NLT which also including the $500,000 paid during 2020. Furthermore , Sonnet stock also has the right to receive the $20.0 Million aggregate of the potential additional amount of regulatory and commercial milestone payments along with tiered royalties on net sales ranging from 12% to 30%. The ASEAN region to be included in Phase 1b/2a pilot-scale efficacy study with low-dose IL-6 in DPN, in the second half of 2021. Sonnet will continue to manufacture low-dose IL-6 for clinical development as well as commercial purposes. NLT can negotiate the license for commercial rights in Chemotherapy-Induced Peripheral Neuropathy and expansion of territory to include China and India.

Management View on Agreement:

Founder and CEO of Sonnet stock Pankaj Mohan expressed excitement for the opportunity of advancing the diabetic peripheral neuropathy program of Sonnet by partnering with NLT. Pankaj thinks that this agreement will expand the market dynamics of the SONN stock and will remove some of the development burdens of the SONN stock. He further added that this agreement is one step closer to a new treatment for patients who are suffering from diabetic peripheral neuropathy.

Conclusion:

Momentum was already built for SONN stock and recent news has added more hype to the rising SONN stock price. It seems that SONN stock is developing with time but deep fundamental as well as technical analysis is necessary before adding this stock to the portfolio.

May 3, 2021
GameStop Corp. (GME) stock rises in the Pre-Market: Why is it so?

GameStop Corp. (GME) announced its expansion of North America Fulfillment and elimination of long-term debt after which the GME stock happened to be green in today’s pre-market on May 3, 2021, after bearing the fall in the previous trading session. GME stock saw a push of 1.30% to reach $175.85 a share at the time of this writing. GME stock went down by 1.48% at the previous closing. Let’s discuss the recent events of GME stock in detail.

Expansion of Fulfillment Network:

GME stock contracted for a 700,000 square foot fulfillment center in York, Pennsylvania in order to expand its North American fulfillment network to support transformation. This facility will support eCommerce and fulfillment needs and is expected to be operational by the fourth quarter of the year 2021. Management of GME stock is optimistic that its fulfillment center in York, Pennsylvania will pave the way for the growth of product offering of GME and accelerate the shipping process across the east coast.

Elimination of long-term debt:

GME stock today also announced its elimination from long-term debt according to which GME stock has completed its voluntary early redemption of $216.4 million of its 10.0% Senior Notes due 2023. This early redemption has covered all the principal amount of outstanding 10% senior notes which means that the GME stock has weaned itself from long-term depth. The freedom from the long-term debt will help GameStop stock to support future transformations and will strengthen the GME’s balance sheet.

Completion of At-The-Market Equity Offering:

On April 26, 2021, GME stock competed for its previously announced at-the-market equity offering program(ATM) pursuant to which GME stock sold 3.5 million shares of its common stock via the ATM offering. The aggregate proceeds resulting from this offering were totaled approximately $551 million without deducting the commissions and offering related expenses.Net proceeds will be used in GameStop’s transformation along with general corporate purposes as well as further strengthening of its balance sheet.

Conclusion:

Investors are responding to the recent couple of news related to GameStop’s expansion of North America Fulfillment and elimination of its long-term debt. GameStop is now well-positioned for its transformation as well as to strengthen its balance sheet. In a nutshell, GME stock can be a good bet for investors in the long run.

May 3, 2021